Research Roundup

SGLT2 inhibitors, NSAIDs, budesonide-formoterol reliever therapy and medication review in RACFs SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes A systematic review of 4 studies provides substantiveevidence supporting the use of SGLT2 inhibitors to prevent major kidney outcomes in people with type 2 diabetes. SGLT2 inhibitors reduced the risk

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Health ‘blitz’ on ORT
Next ‘My trust has been broken.’